Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Last updated: 2022
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20221 results available
- November 20223 results available
- October 20223 results available
- September 20224 results available
- August 20225 results available
- July 20222 results available
- June 20222 results available
- May 20221 results available
- March 20224 results available
- February 20223 results available
- January 20223 results available
Displaying 16 - 30 of 31 items.
Unauthorized health products seized from Productos Latinos El Aguila in Leamington, Ontario
AlertPublic advisory | 2022-08-05
IMVAMUNE Vaccine: Updated Storage Conditions and Shelf Life
AlertHealth professional risk communication | 2022-07-29
Unauthorized health products seized from three herbal medicine stores in Calgary, Alberta
AlertPublic advisory | 2022-06-16
Distribution of a New Presentation of SPIKEVAX (elasomeran) COVID-19 Vaccine (0.10 mg/mL in 2.5 mL multidose vial) with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-06-06
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
AlertHealth professional risk communication | 2022-03-15
Ranitidine products recalled because of a nitrosamine impurity
AlertInformation update | 2022-03-11
Anticipated shortage of euthanasia products for animals
AlertHealth professional risk communication | 2022-03-10
0.9% Sodium Chloride Injection, USP and Lactated Ringer’s Injection, USP - Potential Leak During Pressure Infusion
AlertHealth professional risk communication | 2022-03-09
Distribution of NUVAXOVID with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-02-23
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
AlertHealth professional risk communication | 2022-02-03
Health Canada warns that products sold by Kerela Ayurvedic & Natural Herbal Consultation in Toronto, ON, may pose serious health risks
AlertPublic advisory | 2022-02-01
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
AlertHealth professional risk communication | 2022-01-12